Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

NCT07188012 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

GENETIC: SPOT-03

Sponsor

Shanghai Siponuoyin Biotechnology Co Ltd

Collaborators

[object Object]